A pragmatic, open-label, multi-center, randomized controlled clinical trial on the rotational use of interfaces vs standard of care in patients treated with noninvasive positive pressure ventilation for acute hypercapnic respiratory failure: the ROTAtional-USE of interface STUDY (ROTA-USE STUDY)

In the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute respiratory failure. Pressure ulcers are a frequently observed NIV-related adverse effect, directly related to interface type and exposure time. Switching to a diffe...

Full description

Saved in:
Bibliographic Details
Published inCurrent controlled trials in cardiovascular medicine Vol. 24; no. 1; pp. 527 - 14
Main Authors Vaschetto, Rosanna, Gregoretti, Cesare, Scotti, Lorenza, De Vita, Nello, Carlucci, Annalisa, Cortegiani, Andrea, Crimi, Claudia, Mattei, Alessio, Scala, Raffaele, Rocca, Eduardo, Longhini, Federico, Cammarota, Gianmaria, Misseri, Giovanni, Dal Molin, Alberto, Scolletta, Sabino, Nava, Stefano, Maggiore, Salvatore Maurizio, Navalesi, Paolo
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 13.08.2023
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute respiratory failure. Pressure ulcers are a frequently observed NIV-related adverse effect, directly related to interface type and exposure time. Switching to a different interface has been proposed as a solution to improve patient comfort. However, large studies investigating the benefit of this strategy are not available. Thus, the aim of the ROTAtional-USE of interface STUDY (ROTA-USE STUDY) is to investigate whether a protocolized rotational use of interfaces during NIV is effective in reducing the incidence of pressure ulcers. The ROTA-USE STUDY is a pragmatic, parallel arm, open-label, multicenter, spontaneous, non-profit, randomized controlled trial requiring non-significant risk medical devices, with the aim to determine whether a rotational strategy of NIV interfaces is associated with a lower incidence of pressure ulcers compared to the standard of care. In the intervention group, NIV mask will be randomly chosen and rotated every 6 h. In the control group, mask will be chosen according to the standard of care of the participating centers and changed in case of discomfort or in the presence of new pressure sores. In both groups, the skin underneath the mask will be inspected every 12 h for any possible damage by blinded assessors. The primary outcome is the proportion of patients developing new pressure sores at 36 h from randomization. The secondary outcomes are (i) onset of pressure sores measured at different time points, i.e., 12, 24, 36, 48, 60, 72, 84, and 96 h; (ii) number and stage of pressure sores and comfort measured at 12, 24, 36, 48, 60, 72, 84, and 96 h; and (iii) the economic impact of the protocolized rotational use of interfaces. A sample size of 239 subjects per group (intervention and control) is estimated to detect a 10% absolute difference in the proportion of patients developing pressure sores at 36 h. The development of pressure ulcers is a common side effect of NIV that negatively affects the patients' comfort and tolerance, often leading to NIV failure and adverse outcomes. The ROTA-USE STUDY will determine whether a protocolized rotational approach can reduce the incidence, number, and severity of pressure ulcers in NIV-treated patients. ClinicalTrials.gov NCT05513508. Registered on August 24, 2022.
AbstractList BackgroundIn the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute respiratory failure. Pressure ulcers are a frequently observed NIV-related adverse effect, directly related to interface type and exposure time. Switching to a different interface has been proposed as a solution to improve patient comfort. However, large studies investigating the benefit of this strategy are not available. Thus, the aim of the ROTAtional-USE of interface STUDY (ROTA-USE STUDY) is to investigate whether a protocolized rotational use of interfaces during NIV is effective in reducing the incidence of pressure ulcers.MethodsThe ROTA-USE STUDY is a pragmatic, parallel arm, open-label, multicenter, spontaneous, non-profit, randomized controlled trial requiring non-significant risk medical devices, with the aim to determine whether a rotational strategy of NIV interfaces is associated with a lower incidence of pressure ulcers compared to the standard of care. In the intervention group, NIV mask will be randomly chosen and rotated every 6 h. In the control group, mask will be chosen according to the standard of care of the participating centers and changed in case of discomfort or in the presence of new pressure sores. In both groups, the skin underneath the mask will be inspected every 12 h for any possible damage by blinded assessors. The primary outcome is the proportion of patients developing new pressure sores at 36 h from randomization. The secondary outcomes are (i) onset of pressure sores measured at different time points, i.e., 12, 24, 36, 48, 60, 72, 84, and 96 h; (ii) number and stage of pressure sores and comfort measured at 12, 24, 36, 48, 60, 72, 84, and 96 h; and (iii) the economic impact of the protocolized rotational use of interfaces. A sample size of 239 subjects per group (intervention and control) is estimated to detect a 10% absolute difference in the proportion of patients developing pressure sores at 36 h.DiscussionThe development of pressure ulcers is a common side effect of NIV that negatively affects the patients’ comfort and tolerance, often leading to NIV failure and adverse outcomes. The ROTA-USE STUDY will determine whether a protocolized rotational approach can reduce the incidence, number, and severity of pressure ulcers in NIV-treated patients.Trial registrationClinicalTrials.gov NCT05513508. Registered on August 24, 2022.
In the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute respiratory failure. Pressure ulcers are a frequently observed NIV-related adverse effect, directly related to interface type and exposure time. Switching to a different interface has been proposed as a solution to improve patient comfort. However, large studies investigating the benefit of this strategy are not available. Thus, the aim of the ROTAtional-USE of interface STUDY (ROTA-USE STUDY) is to investigate whether a protocolized rotational use of interfaces during NIV is effective in reducing the incidence of pressure ulcers. The ROTA-USE STUDY is a pragmatic, parallel arm, open-label, multicenter, spontaneous, non-profit, randomized controlled trial requiring non-significant risk medical devices, with the aim to determine whether a rotational strategy of NIV interfaces is associated with a lower incidence of pressure ulcers compared to the standard of care. In the intervention group, NIV mask will be randomly chosen and rotated every 6 h. In the control group, mask will be chosen according to the standard of care of the participating centers and changed in case of discomfort or in the presence of new pressure sores. In both groups, the skin underneath the mask will be inspected every 12 h for any possible damage by blinded assessors. The primary outcome is the proportion of patients developing new pressure sores at 36 h from randomization. The secondary outcomes are (i) onset of pressure sores measured at different time points, i.e., 12, 24, 36, 48, 60, 72, 84, and 96 h; (ii) number and stage of pressure sores and comfort measured at 12, 24, 36, 48, 60, 72, 84, and 96 h; and (iii) the economic impact of the protocolized rotational use of interfaces. A sample size of 239 subjects per group (intervention and control) is estimated to detect a 10% absolute difference in the proportion of patients developing pressure sores at 36 h. The development of pressure ulcers is a common side effect of NIV that negatively affects the patients' comfort and tolerance, often leading to NIV failure and adverse outcomes. The ROTA-USE STUDY will determine whether a protocolized rotational approach can reduce the incidence, number, and severity of pressure ulcers in NIV-treated patients. ClinicalTrials.gov NCT05513508. Registered on August 24, 2022.
In the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute respiratory failure. Pressure ulcers are a frequently observed NIV-related adverse effect, directly related to interface type and exposure time. Switching to a different interface has been proposed as a solution to improve patient comfort. However, large studies investigating the benefit of this strategy are not available. Thus, the aim of the ROTAtional-USE of interface STUDY (ROTA-USE STUDY) is to investigate whether a protocolized rotational use of interfaces during NIV is effective in reducing the incidence of pressure ulcers. The ROTA-USE STUDY is a pragmatic, parallel arm, open-label, multicenter, spontaneous, non-profit, randomized controlled trial requiring non-significant risk medical devices, with the aim to determine whether a rotational strategy of NIV interfaces is associated with a lower incidence of pressure ulcers compared to the standard of care. In the intervention group, NIV mask will be randomly chosen and rotated every 6 h. In the control group, mask will be chosen according to the standard of care of the participating centers and changed in case of discomfort or in the presence of new pressure sores. In both groups, the skin underneath the mask will be inspected every 12 h for any possible damage by blinded assessors. The primary outcome is the proportion of patients developing new pressure sores at 36 h from randomization. The secondary outcomes are (i) onset of pressure sores measured at different time points, i.e., 12, 24, 36, 48, 60, 72, 84, and 96 h; (ii) number and stage of pressure sores and comfort measured at 12, 24, 36, 48, 60, 72, 84, and 96 h; and (iii) the economic impact of the protocolized rotational use of interfaces. A sample size of 239 subjects per group (intervention and control) is estimated to detect a 10% absolute difference in the proportion of patients developing pressure sores at 36 h. The development of pressure ulcers is a common side effect of NIV that negatively affects the patients' comfort and tolerance, often leading to NIV failure and adverse outcomes. The ROTA-USE STUDY will determine whether a protocolized rotational approach can reduce the incidence, number, and severity of pressure ulcers in NIV-treated patients.
Abstract Background In the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute respiratory failure. Pressure ulcers are a frequently observed NIV-related adverse effect, directly related to interface type and exposure time. Switching to a different interface has been proposed as a solution to improve patient comfort. However, large studies investigating the benefit of this strategy are not available. Thus, the aim of the ROTAtional-USE of interface STUDY (ROTA-USE STUDY) is to investigate whether a protocolized rotational use of interfaces during NIV is effective in reducing the incidence of pressure ulcers. Methods The ROTA-USE STUDY is a pragmatic, parallel arm, open-label, multicenter, spontaneous, non-profit, randomized controlled trial requiring non-significant risk medical devices, with the aim to determine whether a rotational strategy of NIV interfaces is associated with a lower incidence of pressure ulcers compared to the standard of care. In the intervention group, NIV mask will be randomly chosen and rotated every 6 h. In the control group, mask will be chosen according to the standard of care of the participating centers and changed in case of discomfort or in the presence of new pressure sores. In both groups, the skin underneath the mask will be inspected every 12 h for any possible damage by blinded assessors. The primary outcome is the proportion of patients developing new pressure sores at 36 h from randomization. The secondary outcomes are (i) onset of pressure sores measured at different time points, i.e., 12, 24, 36, 48, 60, 72, 84, and 96 h; (ii) number and stage of pressure sores and comfort measured at 12, 24, 36, 48, 60, 72, 84, and 96 h; and (iii) the economic impact of the protocolized rotational use of interfaces. A sample size of 239 subjects per group (intervention and control) is estimated to detect a 10% absolute difference in the proportion of patients developing pressure sores at 36 h. Discussion The development of pressure ulcers is a common side effect of NIV that negatively affects the patients’ comfort and tolerance, often leading to NIV failure and adverse outcomes. The ROTA-USE STUDY will determine whether a protocolized rotational approach can reduce the incidence, number, and severity of pressure ulcers in NIV-treated patients. Trial registration ClinicalTrials.gov NCT05513508. Registered on August 24, 2022.
Background In the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute respiratory failure. Pressure ulcers are a frequently observed NIV-related adverse effect, directly related to interface type and exposure time. Switching to a different interface has been proposed as a solution to improve patient comfort. However, large studies investigating the benefit of this strategy are not available. Thus, the aim of the ROTAtional-USE of interface STUDY (ROTA-USE STUDY) is to investigate whether a protocolized rotational use of interfaces during NIV is effective in reducing the incidence of pressure ulcers. Methods The ROTA-USE STUDY is a pragmatic, parallel arm, open-label, multicenter, spontaneous, non-profit, randomized controlled trial requiring non-significant risk medical devices, with the aim to determine whether a rotational strategy of NIV interfaces is associated with a lower incidence of pressure ulcers compared to the standard of care. In the intervention group, NIV mask will be randomly chosen and rotated every 6 h. In the control group, mask will be chosen according to the standard of care of the participating centers and changed in case of discomfort or in the presence of new pressure sores. In both groups, the skin underneath the mask will be inspected every 12 h for any possible damage by blinded assessors. The primary outcome is the proportion of patients developing new pressure sores at 36 h from randomization. The secondary outcomes are (i) onset of pressure sores measured at different time points, i.e., 12, 24, 36, 48, 60, 72, 84, and 96 h; (ii) number and stage of pressure sores and comfort measured at 12, 24, 36, 48, 60, 72, 84, and 96 h; and (iii) the economic impact of the protocolized rotational use of interfaces. A sample size of 239 subjects per group (intervention and control) is estimated to detect a 10% absolute difference in the proportion of patients developing pressure sores at 36 h. Discussion The development of pressure ulcers is a common side effect of NIV that negatively affects the patients' comfort and tolerance, often leading to NIV failure and adverse outcomes. The ROTA-USE STUDY will determine whether a protocolized rotational approach can reduce the incidence, number, and severity of pressure ulcers in NIV-treated patients. Trial registration ClinicalTrials.gov NCT05513508. Registered on August 24, 2022. Keywords: Noninvasive ventilation, Hypercapnic acute respiratory failure, Pressure ulcers, Rotational use of interfaces
In the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute respiratory failure. Pressure ulcers are a frequently observed NIV-related adverse effect, directly related to interface type and exposure time. Switching to a different interface has been proposed as a solution to improve patient comfort. However, large studies investigating the benefit of this strategy are not available. Thus, the aim of the ROTAtional-USE of interface STUDY (ROTA-USE STUDY) is to investigate whether a protocolized rotational use of interfaces during NIV is effective in reducing the incidence of pressure ulcers.BACKGROUNDIn the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute respiratory failure. Pressure ulcers are a frequently observed NIV-related adverse effect, directly related to interface type and exposure time. Switching to a different interface has been proposed as a solution to improve patient comfort. However, large studies investigating the benefit of this strategy are not available. Thus, the aim of the ROTAtional-USE of interface STUDY (ROTA-USE STUDY) is to investigate whether a protocolized rotational use of interfaces during NIV is effective in reducing the incidence of pressure ulcers.The ROTA-USE STUDY is a pragmatic, parallel arm, open-label, multicenter, spontaneous, non-profit, randomized controlled trial requiring non-significant risk medical devices, with the aim to determine whether a rotational strategy of NIV interfaces is associated with a lower incidence of pressure ulcers compared to the standard of care. In the intervention group, NIV mask will be randomly chosen and rotated every 6 h. In the control group, mask will be chosen according to the standard of care of the participating centers and changed in case of discomfort or in the presence of new pressure sores. In both groups, the skin underneath the mask will be inspected every 12 h for any possible damage by blinded assessors. The primary outcome is the proportion of patients developing new pressure sores at 36 h from randomization. The secondary outcomes are (i) onset of pressure sores measured at different time points, i.e., 12, 24, 36, 48, 60, 72, 84, and 96 h; (ii) number and stage of pressure sores and comfort measured at 12, 24, 36, 48, 60, 72, 84, and 96 h; and (iii) the economic impact of the protocolized rotational use of interfaces. A sample size of 239 subjects per group (intervention and control) is estimated to detect a 10% absolute difference in the proportion of patients developing pressure sores at 36 h.METHODSThe ROTA-USE STUDY is a pragmatic, parallel arm, open-label, multicenter, spontaneous, non-profit, randomized controlled trial requiring non-significant risk medical devices, with the aim to determine whether a rotational strategy of NIV interfaces is associated with a lower incidence of pressure ulcers compared to the standard of care. In the intervention group, NIV mask will be randomly chosen and rotated every 6 h. In the control group, mask will be chosen according to the standard of care of the participating centers and changed in case of discomfort or in the presence of new pressure sores. In both groups, the skin underneath the mask will be inspected every 12 h for any possible damage by blinded assessors. The primary outcome is the proportion of patients developing new pressure sores at 36 h from randomization. The secondary outcomes are (i) onset of pressure sores measured at different time points, i.e., 12, 24, 36, 48, 60, 72, 84, and 96 h; (ii) number and stage of pressure sores and comfort measured at 12, 24, 36, 48, 60, 72, 84, and 96 h; and (iii) the economic impact of the protocolized rotational use of interfaces. A sample size of 239 subjects per group (intervention and control) is estimated to detect a 10% absolute difference in the proportion of patients developing pressure sores at 36 h.The development of pressure ulcers is a common side effect of NIV that negatively affects the patients' comfort and tolerance, often leading to NIV failure and adverse outcomes. The ROTA-USE STUDY will determine whether a protocolized rotational approach can reduce the incidence, number, and severity of pressure ulcers in NIV-treated patients.DISCUSSIONThe development of pressure ulcers is a common side effect of NIV that negatively affects the patients' comfort and tolerance, often leading to NIV failure and adverse outcomes. The ROTA-USE STUDY will determine whether a protocolized rotational approach can reduce the incidence, number, and severity of pressure ulcers in NIV-treated patients.ClinicalTrials.gov NCT05513508. Registered on August 24, 2022.TRIAL REGISTRATIONClinicalTrials.gov NCT05513508. Registered on August 24, 2022.
ArticleNumber 527
Audience Academic
Author Scolletta, Sabino
Cammarota, Gianmaria
Dal Molin, Alberto
Navalesi, Paolo
Maggiore, Salvatore Maurizio
Scala, Raffaele
Longhini, Federico
Crimi, Claudia
Carlucci, Annalisa
Rocca, Eduardo
Nava, Stefano
Scotti, Lorenza
Cortegiani, Andrea
De Vita, Nello
Mattei, Alessio
Misseri, Giovanni
Vaschetto, Rosanna
Gregoretti, Cesare
Author_xml – sequence: 1
  givenname: Rosanna
  orcidid: 0000-0003-4625-4367
  surname: Vaschetto
  fullname: Vaschetto, Rosanna
– sequence: 2
  givenname: Cesare
  surname: Gregoretti
  fullname: Gregoretti, Cesare
– sequence: 3
  givenname: Lorenza
  surname: Scotti
  fullname: Scotti, Lorenza
– sequence: 4
  givenname: Nello
  surname: De Vita
  fullname: De Vita, Nello
– sequence: 5
  givenname: Annalisa
  surname: Carlucci
  fullname: Carlucci, Annalisa
– sequence: 6
  givenname: Andrea
  surname: Cortegiani
  fullname: Cortegiani, Andrea
– sequence: 7
  givenname: Claudia
  surname: Crimi
  fullname: Crimi, Claudia
– sequence: 8
  givenname: Alessio
  surname: Mattei
  fullname: Mattei, Alessio
– sequence: 9
  givenname: Raffaele
  surname: Scala
  fullname: Scala, Raffaele
– sequence: 10
  givenname: Eduardo
  surname: Rocca
  fullname: Rocca, Eduardo
– sequence: 11
  givenname: Federico
  surname: Longhini
  fullname: Longhini, Federico
– sequence: 12
  givenname: Gianmaria
  surname: Cammarota
  fullname: Cammarota, Gianmaria
– sequence: 13
  givenname: Giovanni
  surname: Misseri
  fullname: Misseri, Giovanni
– sequence: 14
  givenname: Alberto
  surname: Dal Molin
  fullname: Dal Molin, Alberto
– sequence: 15
  givenname: Sabino
  surname: Scolletta
  fullname: Scolletta, Sabino
– sequence: 16
  givenname: Stefano
  surname: Nava
  fullname: Nava, Stefano
– sequence: 17
  givenname: Salvatore Maurizio
  surname: Maggiore
  fullname: Maggiore, Salvatore Maurizio
– sequence: 18
  givenname: Paolo
  surname: Navalesi
  fullname: Navalesi, Paolo
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37574558$$D View this record in MEDLINE/PubMed
BookMark eNp9U01v1DAQDaiIfsAf4IAscSlSU5LYsbNc0KoUqFSpEm0PnCyvPd51lY1T21lUfj2T3Ra6FUJRksnMe29m4pn9bKfzHWTZm7I4LsuGf4glLTjNiwpvUfMiL59ne6Vgdc6rst55ZO9m-zHeFAWjE8peZrtU1Biqm71nh1PSBzVfquT0EfE9dHmrZtAekeXQJpdr6BKEIxJUZ_zS_QJDtO9S8G07mq3rnFYtScHh03ckLYAEn1DOd-gZIhBviRtFrNIQySqSmFBMBTNGtAqAYdIjA1NFVAKVUPqnSwuCDbtupaJbAel9dGltBIhxQNoKCa5dpyLWB6L0kIAs7noIWvVYGEFk74JKPtwRq1yLrI_rEr9fXE03JebXl6dbJZLLq-vPP8jhCFkH19_vX2UvrGojvL5_H2TXX06vTr7l5xdfz06m57muOUu5qIGCMKxQTNVUUG0VZUUDglsLogQxqdSkmPDaUGpKY2k9E9xYwxUzBaD3IDvb6BqvbmQf3FKFO-mVk2uHD3OpAh5WC7KmM1ppYIJTxoDPZpjbKGGtMRQqA6j1aaPVD7MlmPEsg2q3RLcjnVvIuV_JsmAVo6xChcN7heBvB4hJLl3U0LaqAz9EWTV1IcpJ05QIffcEeuOHgH94RLGJqDhO3F_UXGEHrrMeE-tRVE4FL3gzKShH1PE_UHgZWDqcP7AO_VuEt487_dPiw6AjoNkAdPAxBrBSu82UorJrsWM57pTc7JTEnZLrnZJjY9UT6oP6f0i_ARl3KQY
CitedBy_id crossref_primary_10_3389_fmed_2024_1364475
crossref_primary_10_4187_respcare_11886
crossref_primary_10_1016_j_heliyon_2025_e42500
Cites_doi 10.1159/000509762
10.12968/jowc.2017.26.3.128
10.1371/journal.pone.0211476
10.1056/NEJMoa1503326
10.1093/ageing/afh086
10.1007/s00134-002-1208-7
10.1111/j.1742-481X.2007.00337.x
10.1016/j.apnr.2014.05.005
10.1097/01.CCM.0000178176.51024.82
10.1164/rccm.201106-1094OC
10.1016/j.rmed.2008.08.001
10.4037/ajcc2015386
10.1097/00003246-200006000-00015
10.1183/09031936.00123509
10.1055/s-0034-1383863
10.7861/clinmedicine.8-5-517
10.1007/s42600-020-00114-3
10.4187/respcare.03593
10.1007/s00134-012-2652-7
10.1378/chest.10-1905
10.1164/ajrccm.163.2.9906116
10.1111/j.1532-5415.2009.02307.x
10.1136/thoraxjnl-2015-208209
10.1097/00003246-200203000-00019
10.1213/ane.0b013e3181a1f708
10.1183/13993003.02426-2016
10.1097/01.CCM.0000256725.73993.74
10.1007/s00134-018-5478-0
10.1503/cmaj.130974
10.1183/23120541.00541-2020
10.4187/respcare.02942
10.1186/s13054-021-03595-5
10.1186/cc13175
10.4187/respcare.09625
10.1007/s001340050763
10.1097/CCM.0b013e3181928706
ContentType Journal Article
Copyright 2023. BioMed Central Ltd., part of Springer Nature.
COPYRIGHT 2023 BioMed Central Ltd.
The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
BioMed Central Ltd., part of Springer Nature 2023
Copyright_xml – notice: 2023. BioMed Central Ltd., part of Springer Nature.
– notice: COPYRIGHT 2023 BioMed Central Ltd.
– notice: The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: BioMed Central Ltd., part of Springer Nature 2023
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
KB0
M0S
M1P
NAPCQ
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1186/s13063-023-07560-1
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Medical Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
MEDLINE



MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1745-6215
EndPage 14
ExternalDocumentID oai_doaj_org_article_53b32ce476344e6bb5e3da7ffdd3e2de
PMC10424342
A760689036
37574558
10_1186_s13063_023_07560_1
Genre Multicenter Study
Randomized Controlled Trial
Pragmatic Clinical Trial
Journal Article
GeographicLocations Italy
GeographicLocations_xml – name: Italy
GroupedDBID ---
0R~
123
2-G
29Q
2WC
53G
5VS
6PF
7RV
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACUHS
ADBBV
ADRAZ
ADUKV
AEGXH
AENEX
AFKRA
AFPKN
AHBYD
AHYZX
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
NAPCQ
O5R
O5S
OVT
PGMZT
PHGZM
PHGZT
PIMPY
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
U2A
UKHRP
WOQ
WOW
~8M
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PMFND
3V.
5GY
7XB
8FK
AHMBA
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQQKQ
PQUKI
XSB
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c564t-75e3e7d40a4a5373cfa3408e76ffe71e792a90965d33d1df35b76dfd6a4d0e5d3
IEDL.DBID M48
ISSN 1745-6215
IngestDate Wed Aug 27 01:31:38 EDT 2025
Thu Aug 21 18:40:43 EDT 2025
Fri Jul 11 00:30:40 EDT 2025
Sat Aug 23 12:27:55 EDT 2025
Tue Jun 17 22:22:38 EDT 2025
Tue Jun 10 21:22:05 EDT 2025
Sat Aug 02 01:41:21 EDT 2025
Tue Jul 01 04:01:17 EDT 2025
Thu Apr 24 23:12:25 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Noninvasive ventilation
Pressure ulcers
Hypercapnic acute respiratory failure
Rotational use of interfaces
Language English
License 2023. BioMed Central Ltd., part of Springer Nature.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c564t-75e3e7d40a4a5373cfa3408e76ffe71e792a90965d33d1df35b76dfd6a4d0e5d3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ORCID 0000-0003-4625-4367
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s13063-023-07560-1
PMID 37574558
PQID 2849726455
PQPubID 44365
PageCount 14
ParticipantIDs doaj_primary_oai_doaj_org_article_53b32ce476344e6bb5e3da7ffdd3e2de
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10424342
proquest_miscellaneous_2850719881
proquest_journals_2849726455
gale_infotracmisc_A760689036
gale_infotracacademiconefile_A760689036
pubmed_primary_37574558
crossref_citationtrail_10_1186_s13063_023_07560_1
crossref_primary_10_1186_s13063_023_07560_1
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-08-13
PublicationDateYYYYMMDD 2023-08-13
PublicationDate_xml – month: 08
  year: 2023
  text: 2023-08-13
  day: 13
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Current controlled trials in cardiovascular medicine
PublicationTitleAlternate Trials
PublicationYear 2023
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References J-P Frat (7560_CR11) 2015; 372
C Roberts (7560_CR18) 2008; 8
KEA Burns (7560_CR2) 2014; 186
C Gorecki (7560_CR23) 2009; 57
R Vaschetto (7560_CR31) 2019; 45
S Nava (7560_CR32) 2009; 75
A Ozsancak (7560_CR38) 2011; 139
G Conti (7560_CR22) 1998; 24
AC Davidson (7560_CR1) 2016; 71
R Vaschetto (7560_CR3) 2021; 25
T Bashir (7560_CR30) 2019; 14
C Crimi (7560_CR26) 2010; 36
C Gregoretti (7560_CR34) 2002; 28
JR Curtis (7560_CR35) 2007; 35
G Bennett (7560_CR24) 2004; 33
F Moretto (7560_CR6) 2022; 67
R Vaschetto (7560_CR14) 2014; 18
DP Otero (7560_CR39) 2017; 26
D Chandra (7560_CR10) 2012; 185
K Tomii (7560_CR9) 2009; 103
G Schettino (7560_CR21) 2005; 33
L Brochard (7560_CR12) 2014; 35
S Mehta (7560_CR7) 2001; 163
B Rochwerg (7560_CR13) 2017; 50
BSM da Cunha-Martins (7560_CR37) 2021; 37
R Vaschetto (7560_CR5) 2021; 7
M Schallom (7560_CR17) 2015; 24
R Scala (7560_CR16) 2020; 99
C Girault (7560_CR27) 2009; 37
L Cabrini (7560_CR4) 2015; 60
P Navalesi (7560_CR15) 2000; 28
DR Hess (7560_CR8) 2005; 50
M Antonelli (7560_CR19) 2002; 30
WP Yamaguti (7560_CR20) 2014; 59
KM Newnam (7560_CR29) 2015; 28
P Drew (7560_CR25) 2007; 4
7560_CR36
R Vaschetto (7560_CR28) 2012; 38
F Racca (7560_CR33) 2009; 109
References_xml – volume: 99
  start-page: 800
  year: 2020
  ident: 7560_CR16
  publication-title: Respiration
  doi: 10.1159/000509762
– volume: 26
  start-page: 128
  year: 2017
  ident: 7560_CR39
  publication-title: J Wound Care
  doi: 10.12968/jowc.2017.26.3.128
– volume: 14
  start-page: e0211476
  year: 2019
  ident: 7560_CR30
  publication-title: PLOS One
  doi: 10.1371/journal.pone.0211476
– volume: 372
  start-page: 2185
  year: 2015
  ident: 7560_CR11
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1503326
– volume: 33
  start-page: 230
  year: 2004
  ident: 7560_CR24
  publication-title: Age Ageing
  doi: 10.1093/ageing/afh086
– volume: 28
  start-page: 278
  year: 2002
  ident: 7560_CR34
  publication-title: Intensive Care Med
  doi: 10.1007/s00134-002-1208-7
– volume: 4
  start-page: 149
  year: 2007
  ident: 7560_CR25
  publication-title: Int Wound J
  doi: 10.1111/j.1742-481X.2007.00337.x
– volume: 28
  start-page: 36
  year: 2015
  ident: 7560_CR29
  publication-title: Appl Nurs Res
  doi: 10.1016/j.apnr.2014.05.005
– volume: 33
  start-page: 1976
  year: 2005
  ident: 7560_CR21
  publication-title: Crit Care Med
  doi: 10.1097/01.CCM.0000178176.51024.82
– volume: 185
  start-page: 152
  year: 2012
  ident: 7560_CR10
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201106-1094OC
– volume: 103
  start-page: 67
  year: 2009
  ident: 7560_CR9
  publication-title: Respir Med Elsevier
  doi: 10.1016/j.rmed.2008.08.001
– volume: 24
  start-page: 349
  year: 2015
  ident: 7560_CR17
  publication-title: Am J Crit Care
  doi: 10.4037/ajcc2015386
– volume: 28
  start-page: 1785
  year: 2000
  ident: 7560_CR15
  publication-title: Crit Care Med
  doi: 10.1097/00003246-200006000-00015
– volume: 36
  start-page: 362
  year: 2010
  ident: 7560_CR26
  publication-title: Eur Respir J
  doi: 10.1183/09031936.00123509
– volume: 35
  start-page: 492
  year: 2014
  ident: 7560_CR12
  publication-title: Semin Respir Crit Care Med
  doi: 10.1055/s-0034-1383863
– volume: 8
  start-page: 517
  year: 2008
  ident: 7560_CR18
  publication-title: Clin Med (Lond)
  doi: 10.7861/clinmedicine.8-5-517
– volume: 37
  start-page: 289
  year: 2021
  ident: 7560_CR37
  publication-title: Res Biomed Eng
  doi: 10.1007/s42600-020-00114-3
– volume: 60
  start-page: 586
  year: 2015
  ident: 7560_CR4
  publication-title: Respiratory Care
  doi: 10.4187/respcare.03593
– volume: 38
  start-page: 1599
  year: 2012
  ident: 7560_CR28
  publication-title: Intensive Care Med
  doi: 10.1007/s00134-012-2652-7
– volume: 139
  start-page: 1034
  year: 2011
  ident: 7560_CR38
  publication-title: CHEST Elsevier
  doi: 10.1378/chest.10-1905
– volume: 163
  start-page: 540
  year: 2001
  ident: 7560_CR7
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.163.2.9906116
– volume: 57
  start-page: 1175
  year: 2009
  ident: 7560_CR23
  publication-title: J Am Geriatr Soc
  doi: 10.1111/j.1532-5415.2009.02307.x
– volume: 75
  start-page: 31
  year: 2009
  ident: 7560_CR32
  publication-title: Minerva Anestesiol
– volume: 71
  start-page: ii1
  year: 2016
  ident: 7560_CR1
  publication-title: Thorax
  doi: 10.1136/thoraxjnl-2015-208209
– volume: 30
  start-page: 602
  year: 2002
  ident: 7560_CR19
  publication-title: Crit Care Med
  doi: 10.1097/00003246-200203000-00019
– volume: 109
  start-page: 164
  year: 2009
  ident: 7560_CR33
  publication-title: Anesth Analg
  doi: 10.1213/ane.0b013e3181a1f708
– volume: 50
  start-page: 1602426
  year: 2017
  ident: 7560_CR13
  publication-title: Eur Respir J
  doi: 10.1183/13993003.02426-2016
– volume: 35
  start-page: 932
  year: 2007
  ident: 7560_CR35
  publication-title: Crit Care Med
  doi: 10.1097/01.CCM.0000256725.73993.74
– volume: 45
  start-page: 62
  year: 2019
  ident: 7560_CR31
  publication-title: Intensive Care Med
  doi: 10.1007/s00134-018-5478-0
– volume: 186
  start-page: E112
  year: 2014
  ident: 7560_CR2
  publication-title: CMAJ
  doi: 10.1503/cmaj.130974
– volume: 7
  start-page: 00541
  year: 2021
  ident: 7560_CR5
  publication-title: ERJ Open Res
  doi: 10.1183/23120541.00541-2020
– volume: 59
  start-page: 1530
  year: 2014
  ident: 7560_CR20
  publication-title: Respiratory Care Respiratory Care
  doi: 10.4187/respcare.02942
– volume: 50
  start-page: 924
  year: 2005
  ident: 7560_CR8
  publication-title: Respiratory Care
– volume: 25
  start-page: 189
  year: 2021
  ident: 7560_CR3
  publication-title: Crit Care
  doi: 10.1186/s13054-021-03595-5
– volume: 18
  start-page: R2
  year: 2014
  ident: 7560_CR14
  publication-title: Crit Care
  doi: 10.1186/cc13175
– volume: 67
  start-page: 1138
  year: 2022
  ident: 7560_CR6
  publication-title: Respiratory Care
  doi: 10.4187/respcare.09625
– volume: 24
  start-page: 1283
  year: 1998
  ident: 7560_CR22
  publication-title: Intensive Care Med
  doi: 10.1007/s001340050763
– ident: 7560_CR36
– volume: 37
  start-page: 124
  year: 2009
  ident: 7560_CR27
  publication-title: Crit Care Med
  doi: 10.1097/CCM.0b013e3181928706
SSID ssj0043934
ssj0017864
Score 2.370527
Snippet In the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute respiratory failure....
Background In the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute respiratory...
BackgroundIn the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute respiratory...
Abstract Background In the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 527
SubjectTerms Adult
Airway management
Care and treatment
Chronic obstructive pulmonary disease
Clinical trials
Complications and side effects
Continuous positive airway pressure
Critical care
Extubation
Hospital costs
Humans
Hypercapnic acute respiratory failure
Intensive care
Interfaces
Internal medicine
Intubation
Medical care
Medicine
Noninvasive ventilation
Noninvasive Ventilation - adverse effects
Noninvasive Ventilation - methods
Ostomy
Patient outcomes
Patients
Positive-Pressure Respiration - adverse effects
Positive-Pressure Respiration - methods
Pressure Ulcer - epidemiology
Pressure Ulcer - prevention & control
Pressure ulcers
Quality management
Research design
Respiratory failure
Respiratory insufficiency
Respiratory Insufficiency - therapy
Rotational use of interfaces
Standard of Care
Study Protocol
Treatment Outcome
Ventilators
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwEDZoD4gL4k1hQYOExCIabRM7scOtoF2tkAAJttJyspx4vFuptFXa7oFfz4yTlkZIcOFQKY3taJx8nof9eSzEKyPTzEmlE890NYVBJqXyWVLkaKoic8a7yLb4XJxN1MeL_GLvqC_mhLXpgdsXd5zLSmY1KhoHSmFRVTlK73QI3kvMPLL2JZu3DaZaHUxWVqrtFhlTHK9IU8f1SvppsvFJ2jNDMVv_nzp5zyj1CZN7Fuj0rrjTuY4wbkW-J27i_L649albHH9w42gMy8ZdxhysQ-BjsRL6xDgbQmQNJvxYbIZA1skvfkx_ooeOqD7jy26LJMRzPGAxB3INoVmsu9lC2KwQFgE4v0QTmMgF1yvYzkRwCZPIqBi6VK0riCR2ejTP9cKc532vHbPloWWK8UUM9qlZZF22tDwgNxpcvVkjXFGQ3NRuSYJB85sTAMFNmU3_Lor49cv5uBUxmXw76YkI7O9-hyOuEgvj_zcPxeT05PzDWdIdBJHUeaHWiaZvjtqrkVMul1rWgeA1MqiLEFCnqMvMlZzGxkvpUx9kXunCB1845UdIdx-JA-olPhFQIOEvlLlrlywJOVWhyY8JGsPI1DgQ6RYXtu6ypPNhHTMboyVT2BZLlrBkI5ZsOhBvd22WbY6Qv9Z-z3Db1eT83vEGod52qLf_Qv1AvGawWtZCJF7tus0U1EnO52XHmgJTU5J7MhCHvZqkPep-8RbuttNeK0suS6nJU87zgXi5K-aWzMib42LDdTiSKI2hDj1uR8euS1LnmhqbgTC9cdPrc79kPr2Kuc1TXoqXKnv6P97SM3E7i2PeJKk8FAfrZoPPyYdcVy-iuvgF-qJ0NQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwEDcwJMQL4pvCQIeExBCN1sSO7fCCCto0IQESrFJ5ipzY3iqVpqTtHvjruXPcbhHSHiqlOTs6J-f78s9nxt5onmaGC5VYgqsJ53lSCJslMne6kpnR1gS0xTd5MhFfpvk0JtxWEVa51YlBUdumphz5IarRQqH1zvOPyz8JnRpFq6vxCI1b7DaVLiNIl5ruAq5UaSm2G2W0PFyhvg6rlvhTaOmTtGeMQs3-_zXzFdPUh01esUPH99m96EDCuPviD9hNt3jI7nyNS-SPbhyMYdmas1CJdQh0OFaCH9rNhxCwgwk91rVDQBtlm9-zv85ChKvP6TJulIRwmgc0C0AHEdpmHXOGsFk5aDxQlYnWE5wLLlawzUcQhaBkSIZYsHUFAcqOj6aMLywo-3thCDMPHV6MLkLIj90C9rID5wE602DqzdrBOYbKbW2WyBi0l8gA8GZGmPoPgcUf30_HHYvJ5OdRj0Ugr_cXHFCTQAz_3z1mk-Oj088nSTwOIqlzKdaJyh13yoqRESbnitcehWyknZLeO5U6VWSmoGI2lnObWs_zSknrrTTCjhzefcL2cJTuGQPpUAp9kZtu4RJ9pkoq9Ga8cn6kazdg6VYuyjrWSqcjO-ZliJm0LDtZKlGWyiBLZTpg73d9ll2lkGtbfyJx27WkKt_hRtOelVFplDmveFY7gTZACCerCt-ANcp7a7nLLLL5loS1JF2E7NUmbqnAQVJVr3KsMDzVBTopA7bfa4k6pO6Tt-JeRh22Ki9n3IC93pGpJ-HyFq7ZUBuKJwqtcUBPu9mxGxJXucLOesB0b970xtynLGbnocJ5SgvyXGTPr-frBbubhdmsk5Tvs711u3Ev0UdcV6-CIvgHXtlqNw
  priority: 102
  providerName: ProQuest
Title A pragmatic, open-label, multi-center, randomized controlled clinical trial on the rotational use of interfaces vs standard of care in patients treated with noninvasive positive pressure ventilation for acute hypercapnic respiratory failure: the ROTAtional-USE of interface STUDY (ROTA-USE STUDY)
URI https://www.ncbi.nlm.nih.gov/pubmed/37574558
https://www.proquest.com/docview/2849726455
https://www.proquest.com/docview/2850719881
https://pubmed.ncbi.nlm.nih.gov/PMC10424342
https://doaj.org/article/53b32ce476344e6bb5e3da7ffdd3e2de
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9RAEF9rC-KL-FlP6zGC4IONvWS_EkHkKq2l0CptD86nsMnutgfnXc3dFfWvd2aTOxss4sPlQvaDmTCzM7Pzyyxjr1IeJ4YLHVmCqwnneZQJm0RKurRQiUmtCWiLY3UwEIdDOVxjy-OOmhc4uzG0o_OkBtX47Y_vPz-gwr8PCp-qnRmuwyEbiT-NFjzCaGgDLZMmRT0Sq6wC2t46y6yFjBTauuVHNDfO0TJUoZ7_36v2NbPVhlRes1H799m9xrmEfi0ND9iamzxkd46a9PmjW5t9uKzMeajSug3EaIRC4MbbEHCFEU3rqm1A-2Wn30a_nIUGyj6m2-YjSggnfcB0Aug8QjWdN_uJsJg5mHqgChSVJ6gXXM1guVdBLQQzw2ZoirnOIMDccWraDYYJ7QxfGcLTQ40lo5uwHYDDAi6zBu4BOtpgysXcwQWG0VVpLpEwqP6gBsCbEeHt3wUSTz6f9WsSo8HpXotEII_462M22N87-3gQNSdDRKVUYh5p6bjTVvSMMJJrXnqUt17qtPLe6djpLDEZ1bWxnNvYei4Lray3ygjbc_j0CVtHptxTBsqhQPpMmjqHie5ToTQ6Nl4730tL12HxUgzysimbTqd3jPMQPqUqr0UnR9HJg-jkcYe9WY25rIuG_LP3LknXqicV_A4PptV53qwfueQFT0on0BwI4VRR4BuwRntvLXeJRTJfk2zmpChIXmmaryuQSSrwlfc1Rqpphv5Kh221euJyUrabl9KdL7UxRx8m0-g6S9lhL1fNNJIgehM3XVAfCi2yNEWGNmtlWLHEtUSdk2mHpS01afHcbpmMLkKx85hy81wkz_6bwefsbhL0OI1ivsXW59XCvUDPcV502W091F220e8fnh7i_-7e8ZeTbtiHweunYdwNC8ZvVq50qA
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3rb9MwEDdjk4AviDeFAYcEYohFa2IndpAQ6mDTxh6g0UnjU3Bje5s0mpK2Q_BH8Tdy5yTdIqR924dKafzQuT3fyz_fMfZC8TDSXMjAEFxNWMeDVJgoSGKrBkmkldEebbGbbOyLTwfxwRz729yFIVhlIxO9oDZFTjHyFRSjqUTtHcfvRz8DqhpFp6tNCY2KLbbs71_oso3fbX7E__dlFK2v9T9sBHVVgSCPEzEJZGy5lUZ0tdAxlzx3SGtXWZk4Z2VoZRrplHKiGM5NaByPBzIxziRamK7FtzjvVbYgOLoy82xhdW33y97s3EKqRDRXc1SyMkYN4c9J8SPRtgjClvrzVQL-1wXnlGEbqHlO863fYjdrkxV6FY_dZnN2eIdd26kP5e9eWerBqNSHPvfrMlA5rgBZy54sg0crBjStLZcBtaIpfhz_sQZqgPwJPdZXM8HXD4FiCGiSQllM6iglTMcWCgeU16J0BCCD0zE0ERBqIfAaNkOdInYMHjyPU1OMGYYUbz7VhNKHCqFGDz7IgMM82rOCAwKa76Dz6cTCETrnZa5HSBiUZ1gEcPqYUPxvPYl7n_u9isRg_-tai0QgO_sbLFEX3-i_v77H9i-FVe6zeVylfcggscj3Lo11dVSKVtogkWg_OWldV-W2w8KGL7K8zs5ORUJOMu-lqSSreClDXso8L2Vhh72ZjRlVuUku7L1K7DbrSXnF_YuiPMxqMZXFfMCj3ArUOkLYZDDAX8Bo6Zwx3EYGyXxFzJqR9EPycl1f4sBFUh6xrCfRIVYpmkUdttjqiVIrbzc37J7VUnOcne3xDns-a6aRhAQc2mJKfciDSZXCBT2odsdsSVzGEgerDlOtfdNac7tleHzkc6qHBAHgInp0MV3P2PWN_s52tr25u_WY3Yj8zlZByBfZ_KSc2idooU4GT2uxAOz7ZUuif8qbqSA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwEDdjSBMviG8KAw4JxBCN1sRO7CAhVNimjcFAsEnjKTixvU0aTUnbIfjT-Ou4c5JuEdLe9lApzdnWub0v2z_fMfZU8TDSXMjAEFxNWMeDVJgoSGKr8iTSymiPtthJNvfE-_14f4H9be_CEKyytYneUJuyoD3yVTSjqUTvHcerroFFfF7beDP-GVAFKTppbctp1CKybX__wuXb5PXWGv7Xz6JoY3333WbQVBgIijgR00DGlltpxEALHXPJC4d8D5SViXNWhlamkU4pP4rh3ITG8TiXiXEm0cIMLL7FcS-zK5LHIemY3J8v9kKpEtFe0lHJ6gR9hT8xxY_EKCMIO47Q1wv43yuccYtdyOYZH7hxnV1rglcY1tJ2gy3Y0U229LE5nr91aWUI40of-CywfaDCXAEKmT3ug8ctBjSsrfqA_tGUP47-WAMNVP6YHptLmuAriUA5AgxOoSqnzX4lzCYWSgeU4aJyBCWDkwm0eyFEIRgbkqFJFjsBD6PHoWm3GUa083yiCa8PNVaNHvx2A3bzuM8aGAgYyIMuZlMLh7hMrwo9RsagOkUlgNNHhOd_5Vn88ml3WLMY7H1d77AIFHF_gxVq4on--4vbbO9CBOUOW8RZ2nsMEosa4NJY14emGK_licRIyknrBqqwPRa2cpEVTZ52KhdynPn1mkqyWpYylKXMy1IW9tjLeZ9xnaXk3NZvSdzmLSnDuH9RVgdZY7CymOc8KqxA_yOETfIcfwGjpXPGcBsZZPM5CWtGdhDZK3RznQMnSRnFsqHEpbFKMUDqseVOS7RfRZfcinvW2M9JdqrtPfZkTqaehAkc2XJGbWgtkyqFE7pba8d8SlzGEjurHlMdvenMuUsZHR367OohgQG4iO6fz9djtoT2J_uwtbP9gF2NvGKrIOTLbHFazexDDFWn-SNvE4B9v2gj9A9tTavw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+pragmatic%2C+open-label%2C+multi-center%2C+randomized+controlled+clinical+trial+on+the+rotational+use+of+interfaces+vs+standard+of+care+in+patients+treated+with+noninvasive+positive+pressure+ventilation+for+acute+hypercapnic+respiratory+failure%3A+the+ROTAtional-USE+of+interface+STUDY&rft.jtitle=Trials&rft.au=Vaschetto%2C+Rosanna&rft.au=Gregoretti%2C+Cesare&rft.au=Scotti%2C+Lorenza&rft.au=De+Vita%2C+Nello&rft.date=2023-08-13&rft.pub=BioMed+Central+Ltd&rft.issn=1745-6215&rft.eissn=1745-6215&rft.volume=24&rft.issue=1&rft_id=info:doi/10.1186%2Fs13063-023-07560-1&rft.externalDocID=A760689036
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1745-6215&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1745-6215&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1745-6215&client=summon